1. Home
  2. ABR vs CRVS Comparison

ABR vs CRVS Comparison

Compare ABR & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arbor Realty Trust

ABR

Arbor Realty Trust

N/A

Current Price

$4.98

Market Cap

1.5B

Sector

Real Estate

ML Signal

N/A

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

N/A

Current Price

$14.88

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ABR
CRVS
Founded
2003
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.3B
IPO Year
2003
2016

Fundamental Metrics

Financial Performance
Metric
ABR
CRVS
Price
$4.98
$14.88
Analyst Decision
Hold
Strong Buy
Analyst Count
5
6
Target Price
$9.90
$30.17
AVG Volume (30 Days)
3.9M
785.6K
Earning Date
05-08-2026
05-07-2026
Dividend Yield
15.42%
N/A
EPS Growth
N/A
48.04
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.73
$5.03
52 Week High
$12.58
$26.95

Technical Indicators

Market Signals
Indicator
ABR
CRVS
Relative Strength Index (RSI) 44.16 61.02
Support Level $4.99 $14.24
Resistance Level $5.43 $16.66
Average True Range (ATR) 0.19 0.68
MACD 0.01 0.16
Stochastic Oscillator 40.67 86.63

Price Performance

Historical Comparison
ABR
CRVS

About ABR Arbor Realty Trust

Arbor Realty Trust Inc is a specialized real estate finance company. It invests in a diversified portfolio of structured finance assets in the multifamily, SFR, and commercial real estate markets, consisting of bridge and mezzanine loans, including junior participating interests in first mortgages, preferred, and direct equity. In addition, it may also directly acquire real property and invest in real estate-related notes and certain mortgage-related securities. The company has two business segments, Structured Business and Agency Business. It generates a majority of its revenue from the Structured Business Segment.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.

Share on Social Networks: